IP Verse

Wyeth patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Wyeth opposed by its competitors

Explore Wyeth's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2676679
Aug 28, 2024Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions3
EP3246044
Apr 10, 2024Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens1
EP3572073
Dec 20, 2023Lyophilization Above Collapse1
EP3175853
Nov 1, 2023Antineoplastic Combinations Of Neratinib And Capecitabine1
EP1942868
Oct 4, 2023Sodium Chloride Solution For Drug Reconstitution Or Dilution1
EP3263571
Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof1
EP3000467
Mar 1, 2023Treatment Regimen Utilizing Neratinib For Breast Cancer3
EP2498756
Feb 15, 2023Tablet Formulations Of Neratinib Maleate1
EP3255141
Dec 1, 2021Production Of Antibodies With Improved Glycosylation Pattern2
EP2357250
Oct 6, 2021Production Of Polypeptides2

Top competitors of Wyeth

Top competitors of Wyeth based on patent oppositions.